M

Myriad Genetics Tech Stack

Molecular diagnostics and precision medicine testing for oncology, hereditary cancer, and pharmacogenomics

Biotechnology Research Salt Lake City, Utah 1,001–5,000 employees Founded 1991 Public Company

Myriad Genetics operates a clinical diagnostics and precision medicine business anchored in molecular testing across oncology, hereditary cancer, and pharmacogenomics. The hiring mix is heavily sales-skewed (149 of 235 active roles in sales), reflecting a go-to-market challenge: most pain points center on adoption and clinical uptake rather than test development. Active projects include AI-enhanced cancer risk assessment and structured rollouts of minimal residual disease (MRD) testing, paired with a tech stack (Salesforce, Python, R, dbt, Snowflake, Looker) that supports both clinical data pipelines and sales operations.

Tech Stack 49 technologies

Core StackSalesforce Python dbt Looker Snowflake Adobe Illustrator JavaScript Django React TypeScript PostgreSQL Apex Oracle SQL Server C# R Illumina SQL HITRUST CSF ISO/IEC 27001 Word Excel PowerPoint Komodo InDesign Microsoft Office Salesforce Sales Cloud Service Cloud Tecan ShipStation+18 more

What Myriad Genetics Is Building

◆Challenges

Increasing oncology portfolio adoption
Adopting new diagnostic technology
Increasing adoption of hereditary cancer screening
Increasing prenatal test adoption
Increasing adoption of pharmacogenomic testing
Adopting mrd testing
Expanding oncology sales
Clinical adoption
Securing new oncology business
Retaining key accounts

▲Active Projects

Portfolio integration
Territory plan development
Structured rollout of mrd testing
Clinical education presentations
Ai-enhanced prolaris prostate cancer test launch
Myrisk adoption
Web-apps controlling automation equipment
Clinical development plans
Launch mrd testing
Custom analysis algorithms and pipelines

Hiring Activity

Steady240 roles · 80 in 30d

Department

Sales

149

Healthcare

30

Research

15

Engineering

9

Marketing

7

Ops

4

Product

4

Finance

3

Seniority

Senior

147

Junior

33

Mid

32

Director

8

VP

7

Manager

3

Staff

1

Notable leadership hires: Chief Medical Officer, Product Marketing Director, Lab Director

Company intelligence

Find more companies like Myriad Genetics by tech stack, pain points and active projects

Get started free

About Myriad Genetics

Myriad Genetics is a public biotechnology company founded in 1991 and headquartered in Salt Lake City. The company develops and delivers molecular diagnostic tests that assess disease risk, guide treatment decisions, and inform personalized medicine across oncology, hereditary cancer screening, prenatal testing, and pharmacogenomics. The product portfolio includes hereditary cancer tests (BRCA-related), prostate cancer risk stratification (Prolaris), and pharmacogenomic profiling. Revenue streams are driven by direct-to-provider test ordering and clinical adoption at health systems and oncology practices. The organization operates across the United States and India, with 1,001–5,000 employees.

HeadquartersSalt Lake City, Utah

Company Size1,001–5,000 employees

Founded1991

Hiring MarketsUnited States, India

Frequently Asked Questions

What is Myriad Genetics' tech stack?

Salesforce (Sales Cloud, Service Cloud), Python, R, SQL, dbt, Snowflake, Looker, PostgreSQL, JavaScript, React, TypeScript, Django, and Oracle. Clinical and lab automation use Illumina sequencing platforms and Tecan lab equipment.

What is Myriad Genetics working on?

Current projects include AI-enhanced Prolaris prostate cancer testing, structured rollout of MRD (minimal residual disease) testing, increased adoption of hereditary cancer screening, pharmacogenomics adoption, and web applications controlling lab automation equipment.